Philips Cyriac Abby, Ahamed Rizwan, Abduljaleel Jinsha K P, Rajesh Sasidharan, Augustine Philip
Clinical and Translational Hepatology, Monarch Liver Laboratory, The Liver Institute, Center of Excellence in GI Sciences, Rajagiri Hospital, Aluva, Kerala, India.
Gastroenterology and Advanced GI Endoscopy, Center for Excellence in Gastrointestinal Sciences, Rajagiri Hospital, Aluva, Kerala, India.
J Clin Transl Hepatol. 2023 Feb 28;11(1):15-25. doi: 10.14218/JCTH.2021.00428. Epub 2022 Jun 13.
Intestinal dysbiosis play a role in the adverse outcomes of sepsis and septic shock. However, variations in bacterial diversity and microbiota-related functional metabolic alterations within the gut microbiome in decompensated cirrhosis (DC) patients with infection remain unknown.
We conducted 16-srRNA sequencing on stool samples (=51: sepsis, 27/no sepsis, 24) collected from consecutive DC patients upon admission. Bacterial diversity, significant taxa, and respective metabolic profiling were performed based on subgroup comparisons. Conet/Cytoscape was utilized to identify significant non-random patterns of bacterial copresence and mutual exclusion for clinical events.
Genera associated with pathogenicity in conditions of immune exhaustion (, ) were predominant in patients with sepsis. Metabolic pathways associated with oxidative stress and endotoxemia [lipopolysaccharide (LPS) synthesis and sulfur relay] were significantly upregulated in sepsis. Specific taxa were associated with sites of infection in DC patients. Protective oxidant pathways that increase glutathione were upregulated in those without sepsis. Gammaproteobacteria family of sulfur-metabolizing bacteria, exaggeration of orally predominant pathogens (), and pathways of severe LPS-related hyperinflammatory stress were notable in those with interleukin-6 levels >1,000 pg/dL. Pathogenic genera related to an immune deficient state was significant in DC with ≥2 infection episodes. Megamonas was associated with survival during the same admission.
Specific gut microbiota and their metabolites were associated with sepsis and related events in patients with DC. Identifying beneficial strains that reduce immune exhaustion and supplementation of favorable metabolites could improve therapeutics for DC and sepsis, for which larger prospective, well controlled population-based studies remain an unmet need.
肠道菌群失调在脓毒症和脓毒性休克的不良结局中起作用。然而,感染的失代偿期肝硬化(DC)患者肠道微生物群中细菌多样性和微生物群相关功能代谢改变的差异仍不清楚。
我们对连续入院的DC患者粪便样本(n = 51:脓毒症患者27例,无脓毒症患者24例)进行了16 - srRNA测序。基于亚组比较进行细菌多样性、显著分类群及各自的代谢谱分析。利用Conet/Cytoscape识别临床事件中细菌共存和相互排斥的显著非随机模式。
脓毒症患者中以免疫耗竭状态下与致病性相关的菌属(如……)为主。脓毒症中与氧化应激和内毒素血症相关的代谢途径[脂多糖(LPS)合成和硫传递]显著上调。特定分类群与DC患者的感染部位相关。在无脓毒症的患者中,增加谷胱甘肽的保护性氧化途径上调。硫代谢细菌的γ - 变形菌科、口腔优势病原体(如……)的增多以及严重LPS相关的高炎症应激途径在白细胞介素 - 6水平>1000 pg/dL的患者中显著。与免疫缺陷状态相关的致病菌属在有≥2次感染发作的DC患者中显著。巨单胞菌与同一住院期间的生存相关。
特定的肠道微生物群及其代谢产物与DC患者的脓毒症及相关事件有关。识别可减少免疫耗竭的有益菌株并补充有利代谢产物可能改善DC和脓毒症的治疗,目前仍需要开展更大规模、前瞻性、严格对照的基于人群的研究。